Dengue Fever  Archives

 Dengue Fever
What is the impact of the safety signal on dengue vaccination coverage among adolescents in Brazil?

Published on 16/06/2026 |  Original article (Abstract)  | Percio, Jadher et al. | Vaccine 2026; 77(In progress): 128355 1 min.

The identification of safety signals, such as anaphylaxis linked to the dengue vaccine in adolescents in Brazil, can undermine public trust and necessitate adjustments to vaccination strategies, such as for the strategy restricted to health units. This study compared the vaccination coverage of dengue...

 Dengue Fever
Towards national guidance on dengue and chikungunya vaccination in travellers: Lessons from global recommendations

Published on 21/04/2026 |  Original article (Abstract)  | Bogacka, Anna et al. | Travel medicine and infectious disease 2026; 71(In progress): 102972 1 min.

Dengue and chikungunya are mosquito-borne viral diseases with expanding geographical ranges driven by climate change, urbanisation, and globalisation. In 2024, dengue cases exceeded 14.6 million globally, with more than 12,000 deaths, while chikungunya cases surpassed 410,000 in the Americas. Increasing...

 Dengue Fever
Unveiling the complexity of vaccine hesitancy: A narrative review focusing on dengue vaccination

Published on 10/02/2026 |  Original article (Abstract)  | Rachata Charoenwisedsil et al. | Human vaccines & immunotherapeutics 2025; 21(1): 1 min.

Dengue vaccines face significant challenges, including safety concerns, which contribute to vaccine hesitancy. Addressing this complex issue requires targeted strategies to overcome existing barriers. Through an extensive review of current evidence, we identified key factors contributing to vaccine hesitancy...

 Dengue Fever
Detection of circulating mosquito-borne arboviruses in Brazil using travellers as sentinels

Published on 09/12/2025 |  Original article (Abstract)  | Vavassori, Laura et al. | Travel medicine and infectious disease 2025; 68(In progress): 102936 1 min.

Travellers visiting countries endemic for arboviral diseases may introduce arboviruses to new areas where competent vectors are already present, potentially leading to disease outbreaks in populations that have not previously been exposed. To assess exposure risks for travellers and identify which arboviruses...